https://glp1sa.com/news/ 2026-07-27T08:30:06+00:00 https://glp1sa.com/news/what-the-us-compounding-crackdown-means-for-south-african-patients-sourcing/ 2026-06-21T12:00:00+00:00 https://glp1sa.com/news/novo-nordisk-sues-hims-hers-over-compounded-semaglutide-and-the-inauthentic/ 2026-06-22T12:00:00+00:00 https://glp1sa.com/news/455-adverse-events-dosing-errors-and-counterfeit-apis-the-safety-case-again/ 2026-06-23T12:00:00+00:00 https://glp1sa.com/news/fifth-circuit-grills-fda-on-whether-banning-compounded-glp-1s-was-legal-at/ 2026-06-24T12:00:00+00:00 https://glp1sa.com/news/sahpra-sapc-and-hpcsa-issue-class-i-recall-of-idexis-semaglutide-and-tirzep/ 2026-07-08T12:00:00+00:00 https://glp1sa.com/news/sahpra-recalls-idexis-glp-1-products-healthcare-professionals-warned-of-dis/ 2026-07-09T12:00:00+00:00 https://glp1sa.com/news/455-adverse-events-320-hospitalisations-the-fdas-patient-safety-case-agains/ 2026-07-10T12:00:00+00:00 https://glp1sa.com/news/mounjaro-becomes-south-africas-top-selling-medicine-and-generic-semaglutide/ 2026-07-15T12:00:00+00:00 https://glp1sa.com/news/novo-nordisk-wins-gauteng-high-court-interim-order-against-idexis-appeal-no/ 2026-07-15T12:00:00+00:00 https://glp1sa.com/news/fda-moves-to-permanently-ban-large-scale-compounded-glp-1s-what-it-means-fo/ 2026-07-16T12:00:00+00:00 https://glp1sa.com/news/what-the-july-2026-sa-glp-1-market-shift-means-for-patients-a-summary/ 2026-07-23T12:00:00+00:00 https://glp1sa.com/news/novo-nordisk-launches-lower-cost-ozempic-alternative-extensior-in-south-afr/ 2026-07-23T10:16:31+00:00 https://glp1sa.com/news/idexis-seeks-leave-to-appeal-in-compounded-glp-1-court-battle/ 2026-07-23T10:21:35+00:00 https://glp1sa.com/news/sahpra-approves-sun-pharma-generic-semaglutide-sa-becomes-second-market-aft/ 2026-07-23T12:17:41+00:00 https://glp1sa.com/news/aspen-pharmacare-canada-approval-generic-semaglutide-sa-manufacturing/ 2026-07-24T06:08:40+00:00 https://glp1sa.com/news/hims-hers-pivots-to-novo-nordisk-partnership-after-compounding-crackdown-te/ 2026-07-24T06:58:48+00:00 https://glp1sa.com/news/sahpra-warns-of-criminal-syndicates-behind-illicit-online-glp-1-sales/ 2026-07-24T12:42:52+00:00 https://glp1sa.com/news/sahpra-reviewing-12-generic-semaglutide-applications/ 2026-07-27T06:20:25+00:00 https://glp1sa.com/news/cheaper-ozempic-launching-on-27-july-2026/ 2026-07-27T08:30:06+00:00